Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Colon or Rectum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00016198
What this trial is testing

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Prologue Research International
Not applicableStudy completedNCT05128032
What this trial is testing

Pressure-enabled Delivery in Radioembolization (TriNav Study)

Who this might be right for
Liver CancerHepatocellular CarcinomaMetastatic Colorectal Cancer
Massachusetts General Hospital 29
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03599752
What this trial is testing

Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases

Who this might be right for
Colorectal AdenocarcinomaColorectal Carcinoma Metastatic in the LungStage IV Colorectal Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT00003186
What this trial is testing

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00032110
What this trial is testing

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT04657068
What this trial is testing

ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerOvarian Cancer+6 more
Artios Pharma Ltd 542
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Testing effectiveness (Phase 2)Ended earlyNCT00449163
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Miami 25
Not applicableStudy completedNCT00979329
What this trial is testing

Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

Who this might be right for
Renal Cell CancerColorectal CancerGIST
Radboud University Medical Center 100
Early research (Phase 1)UnknownNCT05872867
What this trial is testing

Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorLung Cancer+5 more
Wellmarker Bio 54
Early research (Phase 1)Study completedNCT01761240
What this trial is testing

Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC

Who this might be right for
Breast CancerPancreatic CancerColorectal Cancer+2 more
Morphotek 27
Not applicableEnded earlyNCT01934179
What this trial is testing

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+9 more
Fox Chase Cancer Center 6
Large-scale testing (Phase 3)UnknownNCT00008281
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Early research (Phase 1)Study completedNCT04868773
What this trial is testing

Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy

Who this might be right for
Colorectal CancerColorectal CarcinomaMetastatic Cancer+1 more
University of California, Irvine 15
Testing effectiveness (Phase 2)Study completedNCT00416494
What this trial is testing

Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Herbert Hurwitz, MD 50
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Testing effectiveness (Phase 2)UnknownNCT00031616
What this trial is testing

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
NewBiotics
Next Page